Acrivon Therapeutics Inc.... (ACRV)
5.29
-0.02 (-0.38%)
At close: Mar 03, 2025, 11:50 AM
Acrivon Therapeutics Common Stock Revenue
Acrivon Therapeutics Common Stock reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending September 30, 2024, Acrivon Therapeutics Common Stock generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
58
Market Cap
164.71M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| 2023-12-31 | 0 | n/a |
| 2022-12-31 | 0 | n/a |
| 2021-12-31 | 0 | n/a |
| 2020-12-31 | 0 | n/a |